Farkas K Christopher

SEC source: 0001628280-26-047233 · wk-form4_1783368410.xml · nonDerivative · entry 1

Farkas K Christopher · CIK 0001621241 · Executive VP and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,274

F1 · kind: Shares were acquired pursuant to the Issuer's Employee Stock Purchase Plan ("ESPP"), under which the Reporting Person agrees to payroll deductions prior to the commencement of a six-month offering period whereby the payroll deductions are accumulated for the purchase of shares at the end of the offering period. This transaction is exempt under both Rule 16b-3(d) and Rule 16b-3(c).

F2 · price: In accordance with the terms of the ESPP, the purchase price is calculated by giving a 15% discount on the average selling price of the Issuer's common stock price on June 30, 2026, the last day of the offering period.

SEC source: 0001628280-26-019786 · wk-form4_1773950503.xml · nonDerivative · entry 1

Farkas K Christopher · CIK 0001621241 · Executive VP and CFO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 4,253

F1 · kind: Sale was made in accordance with a Rule 10b5-1 trading plan adopted by the Reporting Person on November 10, 2025 and maintained by the Reporting Person's financial advisor.

F2 · price: The price reported is the average selling price. The shares were sold in multiple transactions at prices ranging from $681.18 to $699.31, inclusive. The Reporting Person undertakes to provide the SEC, the issuer and any security holder full information regarding the number of shares sold at each separate price.

SEC source: 0001628280-26-019395 · wk-form4_1773864179.xml · nonDerivative · entry 2

Farkas K Christopher · CIK 0001621241 · Executive VP and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,518

F3 · kind: Shares were sold in compliance with the Company's share ownership guidelines whereby the Reporting Person may sell a portion of the vesting award to cover any tax obligations associated with the vesting of the award. The Reporting Person is and remains in compliance with the share ownership guidelines.

F4 · price: The price reported is the average selling price. The shares were sold in multiple transactions at prices ranging from $669.72 to $681.43, inclusive. The Reporting Person undertakes to provide the SEC, the issuer and any security holder full information regarding the number of shares sold at each separate price.

SEC source: 0001628280-26-019395 · wk-form4_1773864179.xml · derivative · entry 3

Farkas K Christopher · CIK 0001621241 · Executive VP and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,366

Underlying: Common Stock · 2,183 shares

Expires 2026-03-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: No price on the date of issue. The restricted stock units were granted as an employee benefit transaction.

F1 · kind: These shares were acquired through a restricted stock unit ("RSU") grant under the Company's 2014 Omnibus Incentive Plan on March 16, 2023. The RSUs cliff vested in Issuer common stock after a three-year vesting period from the date of grant.

F2 · price: No price on the date of issue. The restricted stock units were granted as an employee benefit transaction.

F5 · balance_after: Share total includes dividend credits earned on prior outstanding grants.

SEC source: 0001628280-26-019395 · wk-form4_1773864179.xml · nonDerivative · entry 1

Farkas K Christopher · CIK 0001621241 · Executive VP and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,436

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These shares were acquired through a restricted stock unit ("RSU") grant under the Company's 2014 Omnibus Incentive Plan on March 16, 2023. The RSUs cliff vested in Issuer common stock after a three-year vesting period from the date of grant.

F2 · price: No price on the date of issue. The restricted stock units were granted as an employee benefit transaction.

SEC source: 0001628280-26-016430 · wk-form4_1773173618.xml · derivative · entry 1

Farkas K Christopher · CIK 0001621241 · Executive VP and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,549

Underlying: Common Stock · 645 shares

Expires 2029-03-09

F1 · security: This is a time-based restricted stock unit ("RSU") grant under the Company's 2024 Omnibus Incentive Plan. Each RSU represents a contingent right to receive one share of Issuer common stock. The RSUs will cliff vest after a three-year vesting period from the date of grant, which was March 9, 2026.

F2 · derivative.exercise_price: No price on the date of issue. The restricted stock units were granted as an employee benefit transaction.

F2 · price: No price on the date of issue. The restricted stock units were granted as an employee benefit transaction.

F3 · balance_after: Share total includes dividend credits earned on prior outstanding grants.

SEC source: 0001628280-26-009091 · wk-form4_1771450148.xml · nonDerivative · entry 1

Farkas K Christopher · CIK 0001621241 · Executive VP and CFO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 4,253

F1 · kind: Sale was made in accordance with a 10b5-1 plan adopted by the Reporting Person on November 10, 2025 and maintained by the Reporting Person's financial advisor.

F2 · shares: Shares were sold in compliance with the Company's share ownership guidelines whereby the Reporting Person may sell shares provided the Reporting Person is and remains in compliance with the share ownership guidelines.

F3 · price: The price reported is the average selling price. The shares were sold in multiple transactions at prices ranging from $687.55 to $703.23, inclusive. The Reporting Person undertakes to provide the SEC, the issuer and any security holder full information regarding the number of shares sold at each separate price.

SEC source: 0001628280-26-005812 · wk-form4_1770326688.xml · nonDerivative · entry 2

Farkas K Christopher · CIK 0001621241 · Executive VP and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,358

F3 · kind: Shares were sold in compliance with the Company's share ownership guidelines whereby the executive may sell a portion of the vested shares to cover individual income tax obligations associated with the vesting of the award.

F4 · price: The price reported is the average selling price. The shares were sold in multiple transactions at prices ranging from $609.29 to $660.49, inclusive. The Reporting Person undertakes to provide the SEC, the issuer and any security holder full information regarding the number of shares sold at each separate price.

SEC source: 0001628280-26-005812 · wk-form4_1770326688.xml · nonDerivative · entry 1

Farkas K Christopher · CIK 0001621241 · Executive VP and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,023

F1 · kind: These shares were acquired through a performance share grant under the Company's 2014 Long Term Incentive Plan, whereby the executive received a predetermined number of shares of Curtiss-Wright Common Stock based on the Company's three-year total shareholder return against the performance of its peer group.

F2 · price: Based on February 3, 2026 closing price on the New York Stock Exchange for Curtiss-Wright Common Stock, the date on which the shares vested.

SEC source: 0001628280-26-000770 · wk-form4_1767703529.xml · nonDerivative · entry 1

Farkas K Christopher · CIK 0001621241 · Executive VP and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,253

F1 · kind: Shares were acquired pursuant to the Issuer's Employee Stock Purchase Plan ("ESPP"), under which the Reporting Person agrees to payroll deductions prior to the commencement of a six-month offering period whereby the payroll deductions are accumulated for the purchase of shares at the end of the offering period. This transaction is exempt under both Rule 16b-3(d) and Rule 16b-3(c).

F2 · price: In accordance with the terms of the ESPP, the purchase price is calculated by giving a 15% discount on the average selling price of the Issuer's common stock price on December 31, 2025, the last day of the offering period.

SEC source: 0001628280-25-052054 · wk-form4_1763068734.xml · nonDerivative · entry 1

Farkas K Christopher · CIK 0001621241 · Vice President and CFO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 4,236

F1 · kind: Shares were sold in compliance with the Company's share ownership guidelines whereby the Reporting Person may sell shares provided the Reporting Person is and remains in compliance with the share ownership guidelines.

F2 · shares: Sale was made in accordance with a 10b5-1 plan adopted by the Reporting Person on August 11, 2025 and maintained by the Reporting Person's financial advisor.

F3 · price: The price reported is the average selling price. The shares were sold in multiple transactions at prices ranging from $574.14 to $579.17, inclusive. The Reporting Person undertakes to provide the SEC, the issuer and any security holder full information regarding the number of shares sold at each separate price.

SEC source: 0001628280-25-034129 · wk-form4_1751546672.xml · nonDerivative · entry 1

Farkas K Christopher · CIK 0001621241 · Vice President and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,283

F1 · kind: Shares were acquired pursuant to the Issuer's Employee Stock Purchase Plan ("ESPP"), under which the Reporting Person agrees to payroll deductions prior to the commencement of a six-month offering period whereby the payroll deductions are accumulated for the purchase of shares at the end of the offering period. This transaction is exempt under both Rule 16b-3(d) and Rule 16b-3(c).

F2 · price: In accordance with the terms of the ESPP, the purchase price is calculated by giving a 15% discount on the average selling price of the Issuer's common stock price on June 30, 2025, the last day of the offering period.

SEC source: 0001628280-25-021590 · wk-form4_1746132659.xml · nonDerivative · entry 1

Farkas K Christopher · CIK 0001621241 · Vice President and CFO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 9,253

F1 · kind: Sale was made in accordance with a Rule 10b5-1 trading plan adopted by the Reporting Person on November 5, 2024 and maintained by the Reporting Person's financial advisor

F2 · shares: Shares were sold in compliance with the Company's share ownership guidelines whereby the executive may sell shares provided the Reporting Person is and remains in compliance with the share ownership guidelines.

SEC source: 0001628280-25-013577 · wk-form4_1742334791.xml · nonDerivative · entry 2

Farkas K Christopher · CIK 0001621241 · Vice President and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,033

F3 · kind: Shares were sold in compliance with the Company's share ownership guidelines whereby the Reporting Person may sell a portion of the vesting award to cover any tax obligations associated with the vesting of the award. The Reporting Person is and remains in compliance with the share ownership guidelines.

F4 · price: The price reported is the average selling price. The shares were sold in multiple transactions at prices ranging from $324.21 to $327.35, inclusive. The Reporting Person undertakes to provide the SEC, the issuer and any security holder full information regarding the number of shares sold at each separate price.

SEC source: 0001628280-25-013577 · wk-form4_1742334791.xml · derivative · entry 3

Farkas K Christopher · CIK 0001621241 · Vice President and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,894

Underlying: Common Stock · 2,243 shares

Expires 2025-03-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: No price on the date of issue. The restricted stock units were granted as an employee benefit transaction.

F2 · price: No price on the date of issue. The restricted stock units were granted as an employee benefit transaction.

F1 · derivative.exercise_date: These shares were acquired through a restricted stock unit ("RSU") grant under the Company's 2014 Omnibus Incentive Plan on March 17, 2022. The RSUs cliff vested in Issuer common stock after a three-year vesting period from the date of grant.

F5 · balance_after: Share total includes dividend credits earned on prior outstanding grants.

SEC source: 0001628280-25-013577 · wk-form4_1742334791.xml · nonDerivative · entry 1

Farkas K Christopher · CIK 0001621241 · Vice President and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,955

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These shares were acquired through a restricted stock unit ("RSU") grant under the Company's 2014 Omnibus Incentive Plan on March 17, 2022. The RSUs cliff vested in Issuer common stock after a three-year vesting period from the date of grant.

F2 · price: No price on the date of issue. The restricted stock units were granted as an employee benefit transaction.

SEC source: 0001628280-25-012071 · wk-form4_1741727148.xml · derivative · entry 1

Farkas K Christopher · CIK 0001621241 · Vice President and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,137

Underlying: Common Stock · 1,451 shares

Expires 2028-03-10

F1 · security: This is a time-based restricted stock unit ("RSU") grant under the Company's 2024 Omnibus Incentive Plan. Each RSU represents a contingent right to receive one share of Issuer common stock. The RSUs will cliff vest after a three-year vesting period from the date of grant, which was March 10, 2025.

F2 · derivative.exercise_price: No price on the date of issue. The restricted stock units were granted as an employee benefit transaction.

F2 · price: No price on the date of issue. The restricted stock units were granted as an employee benefit transaction.

F3 · balance_after: Share total includes dividend credits earned on prior outstanding grants.

SEC source: 0001628280-25-004147 · wk-form4_1738799138.xml · nonDerivative · entry 2

Farkas K Christopher · CIK 0001621241 · Vice President and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,712

F3 · kind: Shares were sold in compliance with the Company's share ownership guidelines whereby the executive may sell a portion of the vested shares to pay individual income tax obligations associated with the vesting of the award.

SEC source: 0001628280-25-004147 · wk-form4_1738799138.xml · nonDerivative · entry 1

Farkas K Christopher · CIK 0001621241 · Vice President and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,165

F1 · kind: These shares were acquired through a performance share grant under the Company's 2014 Long Term Incentive Plan, whereby the executive received a predetermined number of shares of Curtiss-Wright Common Stock based on the Company's three year total shareholder return against the performance of its peer group.

F2 · price: Based on February 4, 2025 closing price on the New York Stock Exchange for Curtiss-Wright Common Stock, the date on which the shares vested.

SEC source: 0001628280-25-000499 · wk-form4_1736193014.xml · nonDerivative · entry 1

Farkas K Christopher · CIK 0001621241 · Vice President and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,253

F1 · kind: Shares were purchased pursuant to the Company's Employee Stock Purchase Plan, under which Participant agrees to payroll deductions prior to the commencement of a six month offering period whereby the payroll deductions are accumulated for the purchase of shares at the end of the offering period.

F2 · price: The purchase price is calculated by giving a 15% discount on the average selling price of the Company's common stock price on December 31, 2024, the last day of the offering period.

SEC source: 0001628280-24-031256 · wk-form4_1720193498.xml · nonDerivative · entry 1

Farkas K Christopher · CIK 0001621241 · Vice President and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,223

F1 · kind: Shares were purchased pursuant to the Company's Employee Stock Purchase Plan, under which Participant agrees to payroll deductions prior to the commencement of a six month offering period whereby the payroll deductions are accumulated for the purchase of shares at the end of the offering period

F2 · price: The purchase price is calculated by giving a 15% discount on the average selling price of the Company's common stock price on June 30, 2024, the last day of the offering period.

SEC source: 0001628280-24-012244 · wk-form4_1710968069.xml · nonDerivative · entry 1

Farkas K Christopher · CIK 0001621241 · Vice President and CFO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 9,172

F2 · price: Weighted average selling price of shares sold on March 20, 2024.

F1 · acquired: Sale was made in accordance with a 10b5-1 plan maintained by Reporting Owner's financial advisor.

SEC source: 0001628280-24-012148 · wk-form4_1710955239.xml · derivative · entry 3

Farkas K Christopher · CIK 0001621241 · Vice President and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,670

Underlying: Common Stock · 1,805 shares

Expires 2024-03-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: No price on the date of issue, option having been granted as an employee benefit transaction.

F5 · price: Price is based on the closing market price for the securities on the New York Stock Exchange as of March 19, 2024. The date these units vested.

F4 · derivative.exercise_date: These units were acquired through a restricted share unit grant under the Company's 2014 Long Term Incentive Plan, whereby units vest in common stock shares of Curtiss-Wright Common Stock after a three-year vesting period.

SEC source: 0001628280-24-012148 · wk-form4_1710955239.xml · nonDerivative · entry 2

Farkas K Christopher · CIK 0001621241 · Vice President and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,052

F3 · kind: Shares were sold in compliance with the Company's share ownership guidelines whereby the executive may sell a portion of the vesting award to cover any tax obligations associated with the vesting of the award. The Reporting Person is and remains in compliance with the share ownership guidelines.

SEC source: 0001628280-24-012148 · wk-form4_1710955239.xml · nonDerivative · entry 1

Farkas K Christopher · CIK 0001621241 · Vice President and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,977

F2 · price: No price on the date of issue, option having been granted as an employee benefit transaction.

F1 · acquired: These shares were acquired through a restricted share unit grant under the Company's 2014 Long Term Incentive Plan, whereby units vest in common stock shares of Curtiss-Wright Common Stock after a three-year vesting period.

SEC source: 0001628280-24-011375 · wk-form4_1710521584.xml · derivative · entry 2

Farkas K Christopher · CIK 0001621241 · Vice President and CFO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 13,475

Underlying: Common Stock · 1,601 shares

Expires 2026-03-15

F4 · derivative.exercise_price: No price on the date of issue, option having been granted as an employee benefit transaction.

F5 · date: This is the date the Executive Compensation Committee of the Board of Directors approved the award.

F6 · shares: Number of shares is calculated by taking the amount of the Reporting Person's award and dividing that amount by the closing price of the Registrant's common stock on the date such award was earned.

F7 · price: Price is based on the close price for the Registrant's common stock on March 14, 2024, the date the Executive Compensation Committee of the Board of Directors approved the awards.

SEC source: 0001628280-24-011375 · wk-form4_1710521584.xml · nonDerivative · entry 1

Farkas K Christopher · CIK 0001621241 · Vice President and CFO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 9,172

F1 · kind: Shares were sold in compliance with the Company's share ownership guidelines whereby the executive may sell shares provided the Reporting Person is and remains in compliance with the share ownership guidelines.

F2 · shares: Sale was made in accordance with a 10b5-1 plan maintained by Reporting Owner's financial advisor.

F3 · price: Weighted average selling price of shares sold on March 14, 2024.

SEC source: 0001628280-24-004061 · wk-form4_1707510954.xml · nonDerivative · entry 2

Farkas K Christopher · CIK 0001621241 · Vice President and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,908

F3 · kind: Shares were sold in compliance with the Company's share ownership guidelines whereby the executive may sell a portion of the vested shares to cover individual income tax obligations associated with the vesting of the award.

SEC source: 0001628280-24-004061 · wk-form4_1707510954.xml · nonDerivative · entry 1

Farkas K Christopher · CIK 0001621241 · Vice President and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,914

F1 · kind: These shares were acquired through a performance share grant under the Company's 2014 Long Term Incentive Plan, whereby the executive received a predetermined number of shares of Curtiss-Wright Common Stock based on the Company's three year total shareholder return against the performance of its peer group.

F2 · price: Based on February 7, 2024 closing price on the New York Stock Exchange for Curtiss-Wright Common Stock, the date on which the shares vested.

SEC source: 0001628280-24-000612 · wk-form4_1704483250.xml · nonDerivative · entry 1

Farkas K Christopher · CIK 0001621241 · Vice President and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,172

F1 · kind: Shares were purchased pursuant to the Company's 2018 Employee Stock Purchase Plan, under which Participant agrees to payroll deductions prior to the commencement of a six month offering period whereby the payroll deductions are accumulated for the purchase of shares at the end of the offering period

F2 · price: The purchase price is calculated by giving a 15% discount on the average selling price of the Company's common stock price on December 31, 2023 the last day of the offering period.

SEC source: 0001628280-23-024729 · wk-form4_1689108071.xml · nonDerivative · entry 1

Farkas K Christopher · CIK 0001621241 · Vice President and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,121

F1 · kind: Shares were purchased pursuant to the Company's Employee Stock Purchase Plan, under which Participant agrees to payroll deductions prior to the commencement of a six month offering period whereby the payroll deductions are accumulated for the purchase of shares at the end of the offering period

F2 · price: The purchase price is calculated by giving a 15% discount on the average selling price of the Company's common stock price on June 30, 2023 the last day of the offering period.

SEC source: 0001628280-23-008862 · wf-form4_167949966221077.xml · derivative · entry 3

Farkas K Christopher · CIK 0001621241 · Vice President and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,848

Underlying: Common Stock · 2,018 shares

Expires 2023-03-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · price: No price on the date of issue, option having been granted as an employee benefit transaction.

SEC source: 0001628280-23-008862 · wf-form4_167949966221077.xml · nonDerivative · entry 2

Farkas K Christopher · CIK 0001621241 · Vice President and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,048

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · kind: Shares were sold in compliance with the Company's share ownership guidelines whereby the executive may sell one half of the vested shares to pay individual income tax obligations associated with the vesting of the award.

SEC source: 0001628280-23-008862 · wf-form4_167949966221077.xml · nonDerivative · entry 1

Farkas K Christopher · CIK 0001621241 · Vice President and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,923

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These shares were acquired through a restricted share unit grant under the Company's 2014 Long Term Incentive Plan, whereby units vested in common stock shares of Curtiss-Wright Common Stock after a three year vesting period.

F2 · price: No price on the date of issue, option having been granted as an employee benefit transaction.

SEC source: 0001628280-23-008402 · wf-form4_167906645148959.xml · derivative · entry 1

Farkas K Christopher · CIK 0001621241 · Vice President and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,866

Underlying: Common Stock · 2,164 shares

Expires 2026-03-18

F1 · security: This is a time based restricted share unit grant under the Company's 2014 Long Term Incentive Plan, whereby units vest in common stock shares of Curtiss-Wright Common Stock after a three year vesting period.

F2 · derivative.exercise_price: No price on the date of issue, RSU having been granted as an employee benefit transaction.

F2 · price: No price on the date of issue, RSU having been granted as an employee benefit transaction.

F3 · balance_after: Share total includes dividend credits earned on prior outstanding grants.

SEC source: 0001628280-23-003847 · wf-form4_167656819959643.xml · nonDerivative · entry 2

Farkas K Christopher · CIK 0001621241 · Vice President and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,905

F3 · kind: Shares were sold in compliance with the Company's share ownership guidelines whereby the executive may sell one half of the vested shares to pay individual income tax obligations associated with the vesting of the award.

SEC source: 0001628280-23-003847 · wf-form4_167656819959643.xml · nonDerivative · entry 1

Farkas K Christopher · CIK 0001621241 · Vice President and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,430

F1 · kind: These shares were acquired through a performance share grant under the Company's 2014 Long Term Incentive Plan, whereby the executive received a predetermined number of shares of Curtiss-Wright Common Stock based on the Company's three year total shareholder return against the performance of its peer group.

F2 · price: Based on February 14, 2023 closing price on the New York Stock Exchange for Curtiss-Wright Common Stock, the date on which the shares vested.

SEC source: 0001628280-23-000386 · wf-form4_167293351603685.xml · nonDerivative · entry 1

Farkas K Christopher · CIK 0001621241 · Vice President and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,150

F1 · date: The reporting person is voluntarily reporting this transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c), but the actual transaction took place on 12/31/2022, the last trading day of the option period under the ESPP.

F2 · kind: Shares were purchased pursuant to the Company's 2018 Employee Stock Purchase Plan, under which Participant agrees to payroll deductions prior to the commencement of a six month offering period whereby the payroll deductions are accumulated for the purchase of shares at the end of the offering period

F3 · price: The purchase price is calculated by giving a 15% discount on the average selling price of the Company's common stock price on December 31, 2022 the last day of the offering period.

SEC source: 0001628280-22-018721 · wf-form4_165729126085802.xml · nonDerivative · entry 1

Farkas K Christopher · CIK 0001621241 · Vice President and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,070

F1 · date: The reporting person is voluntarily reporting this transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c), but the actual transaction took place on 06/30/2022, the last trading day of the option period under the ESPP.

F2 · kind: Shares were purchased pursuant to the Company's 2018 Employee Stock Purchase Plan, under which Participant agrees to payroll deductions prior to the commencement of a six month offering period whereby the payroll deductions are accumulated for the purchase of shares at the end of the offering period

F3 · price: The purchase price is calculated by giving a 15% discount on the average selling price of the Company's common stock price on June 30, 2022 the last day of the offering period.

SEC source: 0001628280-22-006564 · wf-form4_164755057876398.xml · derivative · entry 4

Farkas K Christopher · CIK 0001621241 · Vice President and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,674

Underlying: Common Stock · 2,217 shares

Expires 2025-03-16

F6 · shares: This is a time based restricted share unit grant under the Company's 2014 Long Term Incentive Plan, whereby units vest in common stock shares of Curtiss-Wright Common Stock after a three year vesting period.

F5 · price: No price on the date of issue, option having been granted as an employee benefit transaction.

SEC source: 0001628280-22-006564 · wf-form4_164755057876398.xml · derivative · entry 3

Farkas K Christopher · CIK 0001621241 · Vice President and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,457

Underlying: Common Stock · 952 shares

Expires 2022-03-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · price: No price on the date of issue, option having been granted as an employee benefit transaction.

SEC source: 0001628280-22-006564 · wf-form4_164755057876398.xml · nonDerivative · entry 2

Farkas K Christopher · CIK 0001621241 · Vice President and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,982

F3 · kind: Shares were sold in compliance with the Company's share ownership guidelines whereby the executive may sell a portion of his vesting award to cover any tax obligations associated with the vesting of the award.

F4 · price: Average sales price for all shares sold on March 15, 2022.

SEC source: 0001628280-22-006564 · wf-form4_164755057876398.xml · nonDerivative · entry 1

Farkas K Christopher · CIK 0001621241 · Vice President and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,417

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · price: Price is based on the close price for the Registrant's common stock on March 14, 2022, the date the award vested.

F1 · acquired: These shares were acquired through a restricted share unit grant under the Company's 2014 Long Term Incentive Plan, whereby units vested in common stock shares of Curtiss-Wright Common Stock after a three year vesting period.

SEC source: 0001628280-22-002950 · wf-form4_164510714070016.xml · nonDerivative · entry 2

Farkas K Christopher · CIK 0001621241 · Vice President and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,465

F3 · kind: Shares were sold in compliance with the Company's share ownership guidelines whereby the executive may sell a portion of the vesting award to cover any tax obligations associated with the vesting of the award.

SEC source: 0001628280-22-002950 · wf-form4_164510714070016.xml · nonDerivative · entry 1

Farkas K Christopher · CIK 0001621241 · Vice President and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,995

F1 · kind: These shares were acquired through a performance share grant under the Company's 2014 Long Term Incentive Plan, whereby the executive received a predetermined number of shares of Curtiss-Wright Common Stock based on the Company's three year total shareholder return against the performance of its peer group.

F2 · price: Based on February 15, 2022 closing price on the New York Stock Exchange for Curtiss-Wright Common Stock, the date on which the shares vested.

SEC source: 0001628280-22-000443 · wf-form4_164150836330891.xml · nonDerivative · entry 1

Farkas K Christopher · CIK 0001621241 · Vice President and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,958

F1 · date: The reporting person is voluntarily reporting this transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c), but the actual transaction took place on 12/31/2021, the last trading day of the option period under the ESPP.

F2 · kind: Shares were purchased pursuant to the Company's 2018 Employee Stock Purchase Plan, under which Participant agrees to payroll deductions prior to the commencement of a six month offering period whereby the payroll deductions are accumulated for the purchase of shares at the end of the offering period

F3 · price: The purchase price is calculated by giving a 15% discount on the average selling price of the Company's common stock price on December 31, 2021 the last day of the offering period.

SEC source: 0001628280-21-025270 · wf-form4_163970204466801.xml · derivative · entry 1

Farkas K Christopher · CIK 0001621241 · Vice President and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,383

Underlying: Common Stock · 5,660 shares

Expires 2026-12-15

F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock.

F2 · derivative.exercise_date: These restricted stock units are scheduled to cliff vest five years from grant date.

SEC source: 0001628280-21-013682 · wf-form4_162583925716297.xml · nonDerivative · entry 1

Farkas K Christopher · CIK 0001621241 · Vice President and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,874

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Shares were purchased pursuant to the Company's 2018 Employee Stock Purchase Plan, under which Participant agrees to payroll deductions prior to the commencement of a six month offering period whereby the payroll deductions are accumulated for the purchase of shares at the end of the offering period

F2 · price: The purchase price is calculated by giving a 15% discount on the average selling price of the Company's common stock price on June 30, 2021 the last day of the offering period.

SEC source: 0001628280-21-005189 · wf-form4_161618480455735.xml · derivative · entry 1

Farkas K Christopher · CIK 0001621241 · Vice President and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,723

Underlying: Common Stock · 1,779 shares

Expires 2024-03-18

F1 · security: This is a time based restricted share unit grant under the Company's 2014 Long Term Incentive Plan, whereby units vest in common stock shares of Curtiss-Wright Common Stock after a three year vesting period.

F2 · derivative.exercise_price: No price on the date of issue, RSU having been granted as an employee benefit transaction.

F2 · price: No price on the date of issue, RSU having been granted as an employee benefit transaction.

SEC source: 0001628280-21-004950 · wf-form4_161598697401325.xml · nonDerivative · entry 2

Farkas K Christopher · CIK 0001621241 · Vice President and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,762

F3 · kind: Shares were sold in compliance with the Company's share ownership guidelines whereby the executive may sell one half of the vested shares to pay individual income tax obligations associated with the vesting of the award.

F4 · price: Average selling price of shares sold on March 16, 2021.